Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: A serious threat in ICUs

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 219-224

  Candevir Ulu, Aslıhan ^a   Kurtaran, Behice ^a   Inal, Ayşe Seza ^a   Kömür, Süheyla ^a   Kibar, Filiz ^a   Çiçekdemir, Hatice Yapıcı ^a   Bozkurt, Seval ^a   Gürel, Derya ^a   Kılıç, Fatma ^a   Yaman, Akgün ^a   Aksu, Hasan Salih Zeki ^a   Taşova, Yeşim ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Carbapenems; Drug resistance, microbial; Klebsiella pneumonia

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; MEROPENEM; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTERY CATHETER; ARTICLE; BURN INFECTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CATHETER INFECTION; CHILD; DISK DIFFUSION; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NASOGASTRIC TUBE; NEUROSURGERY; NEWBORN; NONHUMAN; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SOFT TISSUE INFECTION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; AUTOMATION; CHEMISTRY; CROSS INFECTION; DRUG EFFECTS; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; SOFTWARE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMATION; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOFTWARE; YOUNG ADULT;

EID: 84982311207     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892516     Document Type: Article

References (29)

1. Peleg AY, Hooper DC: Hospital-acquired infections due to gram-negative bacteria. N Engl J Med, 2010; 362: 1804–13
2. Lautenbach E, Perencevich EN: Addressing the emergence and impact of multidrug-resistant gram-negative organisms: a critical focus for the next decade. Infect Control Hosp Epidemiol, 2014; 35: 333–35
3. Struelens M, Monnet DL, Magiorakos AP et al., the European NDM- 1 Survey Participants: New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill, 2010; 15: pii: 19716
4. Munoz-Price LS, Quinn JP: The spread of Klebsiella pneumonia carbapenemases: a tale of strains, plasmids, and transposons. Clin Infect Dis, 2009; 49: 1739–41
5. Patel G, Huprikar S, Factor SH et al: Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol, 2008; 29: 1099–106
6. Kwak YG, Choi SH, Choo EJ et al: Risk factors for the acquisition of carbapenem- resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist, 2005; 11: 165–69
7. Ahmad M, Urban C, Mariano N et al: Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clin Infect Dis, 1999; 29: 352–55
8. Nguyen M, Eschenauer GA, Bryan M et al: Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis, 2010; 67: 180–84
9. Falagas ME, Rafailidis PI, Kofteridis D et al: Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother, 2007; 60: 1124–30
10. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S et al: Predictors of carbapenem- resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother, 2008; 52: 1028–33
11. Correa L, Martino MD, Siqueira I et al: A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem- resistant Klebsiella pneumoniae infection. BMC Infect Dis, 2013; 13: 80
12. Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control, 2008; 36: 309–32
13. Ahn JY, Song JE, Kim MH et al: Risk factors for the acquisition of carbapenem- resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study. Am J Infect Control, 2014; 42: 621–25
14. Hussein K, Raz-Pasteur A, Finkelstein R et al: Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect, 2013; 83: 307–13
15. Kritsotakis EI, Tsioutis C, Roumbelaki M et al: Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother, 2011; 66: 1383–91
16. Liu SW, Chang HJ, Chia JH et al: Outcomes and characteristics of ertapenem- nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study. J Microbiol Immunol Infect, 2012; 45: 113–19
17. Orsi GB, García-Fernández A, Giordano A et al: Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect, 2011; 78: 54–58
18. Alp E, Perçin D, Colakoğlu S et al: Molecular characterization of carbapenemresistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hosp Infect, 2013; 84: 178–80
19. Labarca J, Poirel L, Özdamar M et al: KPC-producing Klebsiella pneumoniae, finally targeting Turkey. New Microbe New Infect, 2014; 2: 50–51
20. Poirel L, Yilmaz M, Istanbullu A et al: Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother, 2014; 58: 2929–33
21. Gasink LB, Edelstein PH, Lautenbach E et al: Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K.pneumoniae. Infect Control Hosp Epidemiol, 2009; 30: 1180–85
22. Daikos GL, Vryonis E, Psichogiou M et al: Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. J Antimicrob Chemother, 2010; 65: 784–88
23. Wu D, Cai J, Liu J: Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J, 2011; 104: 106–10
24. Kofteridis DP, Valachis A, Dimopoulou D et al: Risk factors for carbapenem- resistant Klebsiella pneumonia infection/colonization: a case-case-control study. J Infect Chemother, 2015; 21: 293–97
25. Routsi C, Pratikaki M, Platsouka E et al: Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients. Intensive Care Med, 2013; 39: 1253–61
26. Borer A, Saidel-Odes L, Eskira S et al: Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control, 2012; 40: 421–25
27. Bhargava A, Hayakawa K, Silverman E et al: Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol, 2014; 35: 398–405
28. Marinosci F, Zizzo A, Coppola A et al: Carbapenem resistance and mortality in institutionalized elderly with urinary infection. J Am Med Dir Assoc, 2013; 14: 513–17
29. Borer A, Saidel-Odes L, Riesenberg K et al: Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol, 2009; 30: 972–76